IP Library Granted Patent US 11,696,991
Granted Patent B2
US 11,696,991 · App. 16/946,231 · Granted Jul 11, 2023

Adaptive cycling for respiratory treatment apparatus

Inventors: Qestra Camille Mulqueeny (Maroubra, AU); Didier Tassaux (Injoux-Genissiat, FR)
A61M16/0069A61M16/0066A61M16/026A61M2016/0027A61M2016/0039A61M2205/50A61M2230/46A61M2230/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,991
App. No.
16/946,231
Granted
Jul 11, 2023
Kind
B2
Abstract

A controller or processor(s) implements detection of respiratory related conditions that may serve as control logic to synchronize pressure treatment delivery with a patient's respiratory cycle. Based on data derived from sensor signals associated with the respiratory treatment, a monitoring device, detector or respiratory treatment apparatus may evaluate flow measures from a flow sensor and distinguish flow attributable to the respiratory treatment apparatus and flow attributable to patient respiratory muscles. The determination may serve as a basis of synchronization criteria that controls pressure levels from a pressure treatment apparatus, such as by evaluating the determined patient generated flow or a relationship between total flow and apparatus flow. In some embodiments, data for the cycling conditions is determined in preliminary treatment cycles during which synchronized pressure changes are controlled according to other cycling criteria. The new cycling conditions are then automatically initiated for control of synchronization in subsequent cycles.

Claims (54)

1. An automated processing method for cycling a respiratory treatment apparatus that controls a delivery of a synchronized respiratory treatment, the method comprising:

determining, by a processor, a first flow measure attributable to a patient respiratory muscle effort based on a first signal received from a flow sensor;

determining, by the processor, a second flow measure attributable to a flow of the respiratory treatment apparatus;

determining, by the processor, a pressure measure based on a second signal received from a pressure sensor;

determining, by the processor, an estimate of the patient respiratory muscle effort as a function of the first flow measure, the second flow measure and the pressure measure; and

deriving, by the processor, a cycling control signal as a function of the estimate of respiratory muscle effort.

2. The method of claim 1 wherein the determining the estimate of the patient respiratory muscle effort is a further function of an estimate of respiratory resistance and compliance.

3. The method of claim 2 wherein the estimate of respiratory resistance and compliance is determined as a function of a portion of patient expiration.

4. The method of claim 3 wherein the estimate of respiratory resistance and compliance is derived from pressure, flow and volume measures taken during the portion of patient expiration.

5. The method of claim 4 wherein the estimate of respiratory resistance and compliance is produced by multiple linear regression processing of the pressure, flow and volume measures taken during the portion of patient expiration beginning at patient expiration and ending when approximately ninety percent of a tidal volume has been expired.

6. The method of claim 1 further comprising determining a peak value of the cycling control signal.

7. The method of claim 6 further comprising cycling the respiratory treatment apparatus as a function of a proportion of the peak value and the cycling control signal.

8. The method of claim 7 wherein deriving the cycling control signal comprises setting the cycling control signal to equal the estimate of the patient respiratory muscle effort if the estimate of respiratory muscle effort is increasing.

9. The method of claim 8 wherein deriving the cycling control signal comprises setting the cycling control signal to zero upon detection of inspiration or if the estimate of the patient respiratory muscle effort is decreasing.

10. A respiratory treatment apparatus for cycling synchronized respiratory pressure treatment through a patient interface to direct a breathable gas, the respiratory treatment apparatus comprising:

a flow generator adapted to couple with the patient interface to generate the breathable gas in inspiratory and expiratory pressure cycles through the patient interface;

a flow sensor to provide a first signal indicative of patient flow through the patient interface;

a pressure sensor to provide a second signal indicative of pressure at the patient interface;

a processor, coupled with the flow generator, the pressure sensor and the flow sensor, the processor configured to:

determine a first flow measure attributable to a patient respiratory muscle effort based on the first signal;

determine a second flow measure attributable to a flow of the respiratory treatment apparatus;

determine a pressure measure based on the second signal;

determine an estimate of the patient respiratory muscle effort as a function of the first flow measure, the second flow measure and the pressure measure; and

derive a cycling control signal as a function of the estimate of respiratory muscle effort.

11. The respiratory treatment apparatus of claim 10 wherein the determination of the estimate of the patient respiratory muscle effort is a further function of an estimate of respiratory resistance and compliance.

12. The respiratory treatment apparatus of claim 11 wherein the estimate of respiratory resistance and compliance is determined as a function of a portion of patient expiration.

13. The respiratory treatment apparatus of claim 12 wherein the estimate of respiratory resistance and compliance is derived from pressure, flow and volume measures taken during the portion of patient expiration.

14. The respiratory treatment apparatus of claim 13 wherein the estimate of respiratory resistance and compliance is produced by multiple linear regression processing of the pressure, flow and volume measures taken during the portion of patient expiration beginning at patient expiration and ending when approximately ninety percent of a tidal volume has been expired.

15. The respiratory treatment apparatus of claim 10 wherein the processor further controls a determination of a peak value of the cycling control signal.

16. The respiratory treatment apparatus of claim 15 wherein the processor further controls cycling the respiratory treatment apparatus as a function of a proportion of the peak value and the cycling control signal.

17. The respiratory treatment apparatus of claim 16 wherein the derivation of the cycling control signal comprises setting the cycling control signal to equal the estimate of the patient respiratory muscle effort if the estimate of respiratory muscle effort is increasing.

18. The respiratory treatment apparatus of claim 17 wherein the derivation of the cycling control signal further comprises setting the cycling control signal to zero upon detection of inspiration or if the estimate of the patient respiratory muscle effort is decreasing.

19. An automated processing method for cycling a respiratory treatment apparatus that controls a delivery of a synchronized respiratory treatment, the method comprising:

determining a flow measure with a flow sensor;

determining a pressure measure with a pressure sensor;

determining, with a processor, an estimate of muscle effort as a function of the flow measure and pressure measure; and

deriving, with the processor, a cycling control signal as a function of the estimate of muscle effort,

wherein the determining the estimate is a further function of an estimate of respiratory resistance and compliance,

wherein the estimate of respiratory resistance and compliance is determined as a function of a portion of patient expiration,

wherein the estimate is derived from pressure, flow and volume measures taken during the portion of patient expiration,

wherein the derived estimate is produced by multiple linear regression processing of the pressure, flow and volume measures taken during the portion of patient expiration beginning at patient expiration and ending when approximately ninety percent of a tidal volume has been expired.

20. A respiratory treatment apparatus for cycling synchronized respiratory pressure treatment through a patient interface to direct a breathable gas, the apparatus comprising:

a flow generator adapted to couple with the patient interface to generate the breathable gas in inspiratory and expiratory pressure cycles through the patient interface;

a flow sensor to provide a signal indicative of patient flow through the patient interface;

a pressure sensor to provide a signal indicative of pressure at the patient interface;

a processor, coupled with the flow generator, the pressure sensor and the flow sensor, the processor configured to control:

a determination of a flow measure with the flow sensor;

a determination of a pressure measure with the pressure sensor;

a determination of an estimate of muscle effort as a function of the flow measure and pressure measure; and

a derivation of a cycling control signal as a function of the estimate of muscle effort,

wherein the determination of the estimate is a further function of an estimate of respiratory resistance and compliance,

wherein the estimate of respiratory resistance and compliance is determined as a function of a portion of patient expiration,

wherein the estimate is derived from pressure, flow and volume measures taken during the portion of patient expiration,

wherein the derived estimate is produced by multiple linear regression processing of the pressure, flow and volume measures taken during the portion of patient expiration beginning at patient expiration and ending when approximately ninety percent of a tidal volume has been expired.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2021
From: MULQUEENY, QESTRA CAMILLE
To: RESMED LIMITED
Reel/Frame 058027/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2021
From: TASSAUX, DIDIER
To: UNIVERSITY HOSPITALS OF GENEVA
Reel/Frame 058028/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2021
From: UNIVERSITY HOSPITALS OF GENEVA
To: RESMED LIMITED
Reel/Frame 058028/0546 →
CHANGE OF NAME Recorded Nov 5, 2021
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 058795/0615 →
Continuity (4)
Continuation 15471943 · Mar 28, 2017
Continuation 13819037
Provisional Application 61377664 · Aug 27, 2010
Related Publication 20200297954A1 · Sep 24, 2020